← Back to Search

Coenzyme Q10 Supplement

Older adults with sarcopenia (drug) for Sarcopenia (COQ10 Trial)

Q: Are enrollees being accepted for this clinical experiment presently?

Data listed on clinicaltrials.gov suggests that this trial is no longer actively recruiting participants, as the last update was posted in August 2022. However, 107 other trials are currently seeking volunteers at present.

Q: Is there a criteria for eligibility to partake in this clinical experiment?

This clinical trial is currently accepting 40 individuals aged 65 to 90 years with sarcopenia. Mandatory criteria includes: being comfortable following the protocol and completing necessary forms, gender identity of either male or female, sedentary lifestyle (≤1 structured exercise session/week), Skeletal Muscle Mass Index (SMI) &#x3C;7.25 kg/m2 for males or &#x3C;5.67 kg/m2 for females via DEXA scan, willingness to sign an approved informed consent form by a Institutional Review Board / Independent Ethics Committee and authorization under HIPAA laws before any participation in the study.

Q: Does the age restriction for this medical experiment include persons younger than 40?

Participants aged 65 to 90 are eligible for this study, with 1 trial exclusive to minors and 104 studies dedicated specifically to the elderly.

Phase < 1

Waitlist Available

Led By Paul Coen, PhD

Research Sponsored by Translational Research Institute for Metabolism and Diabetes, Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up following 28 days of treatment

Awards & highlights

COQ10 Trial Summary

This trial is testing whether CoQ10 supplements can improve muscle strength and function in older adults with sarcopenia.

COQ10 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ following 28 days of treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~following 28 days of treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and following 28 days of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Measurement of platelet CoQ10 level

Measurement of skeletal muscle

COQ10 Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Older adults with sarcopenia (drug)Active Control1 Intervention

Group II: Older adults with sarcopenia (placebo)Placebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor

40 Previous Clinical Trials

3,597 Total Patients Enrolled

2 Trials studying Sarcopenia

275 Patients Enrolled for Sarcopenia

AdventHealth Translational Research InstituteLead Sponsor

48 Previous Clinical Trials

20,181 Total Patients Enrolled

2 Trials studying Sarcopenia

275 Patients Enrolled for Sarcopenia

Paul Coen, PhDPrincipal InvestigatorAdventHealth Translational Research Institute

5 Previous Clinical Trials

191 Total Patients Enrolled

1 Trials studying Sarcopenia

75 Patients Enrolled for Sarcopenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollees being accepted for this clinical experiment presently?

"Data listed on clinicaltrials.gov suggests that this trial is no longer actively recruiting participants, as the last update was posted in August 2022. However, 107 other trials are currently seeking volunteers at present."

Answered by AI

Is there a criteria for eligibility to partake in this clinical experiment?

"This clinical trial is currently accepting 40 individuals aged 65 to 90 years with sarcopenia. Mandatory criteria includes: being comfortable following the protocol and completing necessary forms, gender identity of either male or female, sedentary lifestyle (≤1 structured exercise session/week), Skeletal Muscle Mass Index (SMI) <7.25 kg/m2 for males or <5.67 kg/m2 for females via DEXA scan, willingness to sign an approved informed consent form by a Institutional Review Board / Independent Ethics Committee and authorization under HIPAA laws before any participation in the study."

Answered by AI